Cognition Therapeutics (CGTX) Exchange Rate Effect (2020 - 2023)
Cognition Therapeutics (CGTX) reported Exchange Rate Effect of $1000.0 for Q3 2023, up 133.33% year-over-year from $428.57 in Q3 2022, and up 200.0% on a QoQ basis from -$1000.0 in Q2 2023.
Cognition Therapeutics (CGTX) has 4 years of Exchange Rate Effect data on file, last reported at $1000.0 in Q3 2023.
- Quarterly Exchange Rate Effect rose 133.33% year-over-year to $1000.0 in Q3 2023, while the trailing twelve-month figure through Dec 2023 was $4000.0 (up 500.0% YoY) and the FY2023 annual result came in at $4000.0, up 500.0% from the prior year.
- Exchange Rate Effect climbed to $1000.0 in Q3 2023 per CGTX's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $21000.0 in Q3 2021 and bottomed at -$24000.0 in Q4 2021.
- The 4-year median for Exchange Rate Effect is $0.0 (2022), against an average of -$1900.0.
- The widest annual swing landed in 2022, when Exchange Rate Effect slumped 114.29%; it then jumped 300.0% in 2023.
- Tracing CGTX's Exchange Rate Effect over 4 years: stood at -$19000.0 in 2020, then decreased by 26.32% to -$24000.0 in 2021, then soared by 116.67% to $4000.0 in 2022, then tumbled by 75.0% to $1000.0 in 2023.
- Per Business Quant, the three latest CGTX Exchange Rate Effect figures stand at $1000.0 (Q3 2023), -$1000.0 (Q2 2023), and $4000.0 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | -900,000.00 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -3,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | -24,000.00 |
| Dec 31, 2021 | -24,000.00 |
| Sep 30, 2021 | 21,000.00 |
| Sep 30, 2021 | 21,000.00 |
| Dec 31, 2020 | -19,000.00 |
| Dec 31, 2020 | -19,000.00 |